SCHEMBL4436030

SCHEMBL4436030

CC(C)(C)N1CCN(c2ccc(C(=O)c3ccccc3)cc2N)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.67
SMN1; SMN2 Q16637 5/20 0.67
KDM4E B2RXH2 6/20 0.51
HSD17B10 Q99714 5/20 0.51
ALDH1A1 P00352 5/20 0.51
POLB P06746 4/20 0.50
GAA P10253 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
NR4A1 P22736 1/20 0.49
PRMT1 Q99873 1/20 0.47
HPGD P15428 4/20 0.47
RAB9A P51151 4/20 0.47
MAPK1 P28482 3/20 0.47
ALOX15 P16050 3/20 0.47
TSHR P16473 3/20 0.47
TP53 P04637 2/20 0.47
MAPT P10636 3/20 0.46
LMNA P02545 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11475873 0.85 NPC1 (0.71) NPC1SMN1; SMN2KDM4EHSD17B10ALDH1A1
SCHEMBL4437150 0.84 KDM4E (0.56) NPC1SMN1; SMN2KDM4EHSD17B10ALDH1A1
SCHEMBL11819784 0.84 NPC1 (0.77) NPC1SMN1; SMN2KDM4EHSD17B10ALDH1A1
SCHEMBL11907383 0.83 NPC1 (0.61) NPC1SMN1; SMN2KDM4EHSD17B10ALDH1A1
SCHEMBL11818379 0.82 NPC1 (0.75) NPC1SMN1; SMN2KDM4EHSD17B10ALDH1A1
SCHEMBL10733821 0.82 NPC1 (0.75) NPC1SMN1; SMN2KDM4EHSD17B10ALDH1A1
SCHEMBL11471717 0.80 SMN1; SMN2 (1.00) NPC1SMN1; SMN2KDM4EHSD17B10ALDH1A1
SCHEMBL11908425 0.80 NPC1 (0.71) NPC1SMN1; SMN2KDM4EHSD17B10ALDH1A1
Hydrochloric Acid SCHEMBL11817727 0.79 SMN1; SMN2 (0.97) NPC1SMN1; SMN2KDM4EHSD17B10ALDH1A1
SCHEMBL11907679 0.79 NPC1 (0.70) NPC1SMN1; SMN2KDM4EHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed